Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.40 |
| ▸ | CFTR | P13569 | 6/20 | 0.39 |
| ▸ | CNR2 | P34972 | 10/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL212456 | 0.89 | CNR1 (0.47) | CNR1CFTRCNR2 | |
| SCHEMBL213341 | 0.87 | CNR1 (0.43) | CNR1CFTRCNR2CYP3A4CYP2C9 | |
| SCHEMBL212545 | 0.86 | CNR1 (0.53) | CNR1CFTRCNR2CYP3A4CYP2C9 | |
| SCHEMBL211872 | 0.86 | CNR1 (0.40) | CNR1CFTRCNR2CYP2C9CYP2C19 | |
| SCHEMBL212544 | 0.83 | CNR1 (0.40) | CNR1CFTRCNR2GABRA5 | |
| SCHEMBL216312 | 0.78 | SLC6A3 (0.42) | CNR1CFTRCNR2GABRA5 | |
| SCHEMBL212276 | 0.76 | TRPV1 (0.46) | CNR1CNR2ATM | |
| SCHEMBL213232 | 0.76 | CNR1 (0.49) | CNR1CFTRCNR2GABRA5 | |
| SCHEMBL216677 | 0.76 | PIN1 (0.45) | CYP3A4CYP2C19 | |
| SCHEMBL528736 | 0.76 | CNR1 (0.46) | CNR1CNR2CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088920-B2 | 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents | HOFFMANN-LA ROCHE INC. (US) | 2012-01-03 | — | — | US | disclosed |
| EP-2271632-A1 | 3-TRIFLUOROMETHYL-PYRAZINE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | F. Hoffmann-La Roche AG (CH) | 2011-01-12 | — | — | EP | disclosed |